Jefferies Group’s Agios Pharmaceuticals AGIO Stock Holding History

Jefferies Group’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,000	Closed	-$377K	–	1619
2022 Q2	$377K	Hold	17,000	–	–	﹤0.01%	1097
2022 Q1	$495K	Hold	17,000	–	–	﹤0.01%	1056
2021 Q4	$559K	Buy	+17,000	New	+$684K	﹤0.01%	1149
2021 Q3	–	Sell	-10,300	Closed	-$568K	–	1689
2021 Q2	$568K	Buy	+10,300	New	+$576K	﹤0.01%	1134
2021 Q1	–	Sell	-70,000	Closed	-$3.03M	–	1586
2020 Q4	$3.03M	Buy	70,000 +50,000	+250%	+$1.98M	0.02%	576
2020 Q3	$700K	Buy	+20,000	New	+$877K	0.01%	904
2020 Q1	–	Sell	-30,000	Closed	-$1.43M	–	2005
2019 Q4	$1.43M	Sell	30,000 -35,000	-54%	-$1.32M	0.01%	1250
2019 Q3	$2.11M	Buy	+65,000	New	+$2.69M	0.02%	1050

Other funds holding AGIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Group's AGIO Position: Q3 2022 in Review

Jefferies Group sold out of Agios Pharmaceuticals (AGIO) in Q3 2022, closing a stake of 17,010 shares — an estimated $377K sold.

Jefferies Group first reported a position in AGIO in Q2 2015 and held it in 12 quarters. The position peaked at $1.75M in Q3 2019. 168 funds tracked by Wall St. Rank hold AGIO as of Q3 2022.

Jefferies Group reported no remaining Agios Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Jefferies Group sold 17,010 Agios Pharmaceuticals shares in Q3 2022, an estimated $377K.
Jefferies Group first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 12 quarters.
Jefferies Group's Agios Pharmaceuticals position peaked at $1.75M in Q3 2019.
168 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.